110 related articles for article (PubMed ID: 21484565)
21. Pharmacotherapy of hyperglycemia.
Kulasa KM; Henry RR
Expert Opin Pharmacother; 2009 Oct; 10(15):2415-32. PubMed ID: 19743938
[TBL] [Abstract][Full Text] [Related]
22. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
23. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Herman GA; Stein PP; Thornberry NA; Wagner JA
Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
Penfornis A; Borot S; Raccah D
Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
[TBL] [Abstract][Full Text] [Related]
25. Management of type 2 diabetes: new and future developments in treatment.
Tahrani AA; Bailey CJ; Del Prato S; Barnett AH
Lancet; 2011 Jul; 378(9786):182-97. PubMed ID: 21705062
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.
Cignarelli A; Giorgino F; Vettor R
Arch Physiol Biochem; 2013 Oct; 119(4):139-50. PubMed ID: 23724947
[TBL] [Abstract][Full Text] [Related]
27. Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy.
Iacobellis G; Basilico S; Malavazos AE
Handb Exp Pharmacol; 2022; 274():93-108. PubMed ID: 35156138
[TBL] [Abstract][Full Text] [Related]
28. New drugs for the treatment of type 2 diabetes.
Chowdhury TA; Hossain B
Br J Hosp Med (Lond); 2007 Apr; 68(4):178-83. PubMed ID: 17465090
[TBL] [Abstract][Full Text] [Related]
29. The treatment of type 2 diabetes mellitus in youth : which therapies?
Miller JL; Silverstein JH
Treat Endocrinol; 2006; 5(4):201-10. PubMed ID: 16878999
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic approaches to target inflammation in type 2 diabetes.
Goldfine AB; Fonseca V; Shoelson SE
Clin Chem; 2011 Feb; 57(2):162-7. PubMed ID: 21098138
[TBL] [Abstract][Full Text] [Related]
31. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?
Sathyapalan T; Atkin SL
Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323
[TBL] [Abstract][Full Text] [Related]
32. Targeting the gastrointestinal tract to treat type 2 diabetes.
Bauer PV; Duca FA
J Endocrinol; 2016 Sep; 230(3):R95-R113. PubMed ID: 27496374
[TBL] [Abstract][Full Text] [Related]
33. Type 2 diabetes across generations: from pathophysiology to prevention and management.
Nolan CJ; Damm P; Prentki M
Lancet; 2011 Jul; 378(9786):169-81. PubMed ID: 21705072
[TBL] [Abstract][Full Text] [Related]
34. Diabetes drugs and neurological disorders: new views and therapeutic possibilities.
Patrone C; Eriksson O; Lindholm D
Lancet Diabetes Endocrinol; 2014 Mar; 2(3):256-62. PubMed ID: 24622756
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.
DeFronzo RA; Eldor R; Abdul-Ghani M
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S127-38. PubMed ID: 23882037
[No Abstract] [Full Text] [Related]
36. Inflammation and insulin resistance.
Shoelson SE; Lee J; Goldfine AB
J Clin Invest; 2006 Jul; 116(7):1793-801. PubMed ID: 16823477
[TBL] [Abstract][Full Text] [Related]
37. Update on the protective molecular pathways improving pancreatic beta-cell dysfunction.
Puddu A; Sanguineti R; Mach F; Dallegri F; Viviani GL; Montecucco F
Mediators Inflamm; 2013; 2013():750540. PubMed ID: 23737653
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance and insulin sensitizing agents.
Mastrototaro L; Roden M
Metabolism; 2021 Dec; 125():154892. PubMed ID: 34563556
[TBL] [Abstract][Full Text] [Related]
39. Targeting adipose tissue in the treatment of obesity-associated diabetes.
Kusminski CM; Bickel PE; Scherer PE
Nat Rev Drug Discov; 2016 Sep; 15(9):639-660. PubMed ID: 27256476
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes.
Zamora M; Pardo R; Villena JA
Biochem Pharmacol; 2015 Nov; 98(1):16-28. PubMed ID: 26212547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
